The Diabetes Research Center at the University of Washington has existed for 38 years as part of a national program supported by NIH. It acts as the focal point and umbrella for diabetes research in the Greater Seattle area W .h the goal of promoting an environment of collaborative research on diabetes, obesity and related disorders by (a) providing support to affiliate investigators through its biomedical research cores, (b) sponsoring an enrichment program comprising lectures and symposia to Inform the community of the latest developments in the area, (c) conducting a small pilot and feasibility program that provides grant support for new investigators in diabetes research and to established investigators In other disciplines, (d) ensuring the development of young investigators by providing fellowships for salary support and training In Its research cores, and (e) developing new research methods and technologies for use by investigators. To accomplish this goal, the Center is organized around six biomedical research cores (Cell Function Analysis Core, Cellular and Molecular Imaging Core, Human Studies Core, Immunology and Inflammation Core, Quantitative and Functional Proteomics Core, and Viral Vector and Transgenic Mouse Core) and an Administrative Core that also administers the Pilot and Feasibility Program and the Enrichment Program. Along with the commitment of the University of Washington and other Seattle institutions of research space and additional financial support, the Diabetes Research Center is a dynamic and constantly evolving center that supports 95 Seattle-based affiliate investigators who are making important scientific contributions in the areas of (a) etiology, pathogenesis and treatment of type 1 diabetes, (b) pathophysiology and treatment of type 2 diabetes, (c) obesity and regulation of body weight/composition, (d) microvascular complications of diabetes, (e) inflammation, macrovascular and other complications of diabetes, and (f) clinical trials and large-scale epidemiologic studies.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-S (O2))
Program Officer
Hyde, James F
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Washington
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Kuzma, Jessica N; Cromer, Gail; Hagman, Derek K et al. (2018) Consuming glucose-sweetened, not fructose-sweetened, beverages increases fasting insulin in healthy humans. Eur J Clin Nutr :
Basu, Debapriya; Hu, Yunying; Huggins, Lesley-Ann et al. (2018) Novel Reversible Model of Atherosclerosis and Regression Using Oligonucleotide Regulation of the LDL Receptor. Circ Res 122:560-567
Yi-Frazier, Joyce P; Cochrane, Katie; Whitlock, Kathryn et al. (2018) Trajectories of Acute Diabetes-Specific Stress in Adolescents With Type 1 Diabetes and Their Caregivers Within the First Year of Diagnosis. J Pediatr Psychol 43:645-653
Campos, Carlos A; Bowen, Anna J; Roman, Carolyn W et al. (2018) Encoding of danger by parabrachial CGRP neurons. Nature 555:617-622
Kim, C; Miller, R S; Braffett, B H et al. (2018) Ovarian markers and irregular menses among women with type 1 diabetes in the Epidemiology of Diabetes Interventions and Complications study. Clin Endocrinol (Oxf) 88:453-459
Alpers, Charles E; Hudkins, Kelly L (2018) Pathology identifies glomerular treatment targets in diabetic nephropathy. Kidney Res Clin Pract 37:106-111
Han, Seung Jin; Fujimoto, Wilfred Y; Kahn, Steven E et al. (2018) Change in visceral adiposity is an independent predictor of future arterial pulse pressure. J Hypertens 36:299-305
Wacker, Bradley K; Dronadula, Nagadhara; Bi, Lianxiang et al. (2018) Apo A-I (Apolipoprotein A-I) Vascular Gene Therapy Provides Durable Protection Against Atherosclerosis in Hyperlipidemic Rabbits. Arterioscler Thromb Vasc Biol 38:206-217
Wander, Pandora L; Hayashi, Tomoshige; Sato, Kyoko Kogawa et al. (2018) Design and validation of a novel estimator of visceral adipose tissue area and comparison to existing adiposity surrogates. J Diabetes Complications 32:1062-1067
Lemaitre, Rozenn N; Yu, Chaoyu; Hoofnagle, Andrew et al. (2018) Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study. Diabetes 67:1663-1672

Showing the most recent 10 out of 1296 publications